Results 121 to 130 of about 4,889,938 (291)
Synergistic co‐operation of signal transducer and activator of transcription 5B with activator protein 1 in angiotensin II‐induced angiotensinogen gene activation in vascular smooth muscle cells [PDF]
Mei Han +7 more
openalex +1 more source
Intracellular Catalytic Photooxygenation of α‐Synuclein Amyloid
Amyloid‐selective catalytic photooxygenation reduces amyloid toxicity, aggregation tendencies, and seeding activities. Achieving therapeutic catalysis for intracellular amyloids is challenging due to conflicting oxygenation and reductive cellular environments.
Atsushi Iwai +11 more
wiley +1 more source
Interactions between angiotensin II and arginine vasopressin in water homeostasis [PDF]
Robert W. Schrier
openalex +1 more source
Drug Discovery Applications of Nitroso (Hetero)Arene Derivatives
Nitroso (hetero)aromatic compounds are bioactive molecules with antiviral, anticancer, neuroprotective, and antimicrobial properties. This review highlights their mechanisms of action—oxidative stress, DNA damage, and enzyme inhibition—alongside synthesis, structure–activity relationships, and toxicity challenges, offering insight into their ...
Silvia Roscales, Aurelio G. Csáky
wiley +1 more source
Overview of a multi‐omics based drug repurposing strategy. The systematic drug repurposing strategy included the following steps: (1) osteoporosis driver signaling networks were identified from multi‐omics data; (2) drug functional modules were obtained using a network fusion approach to integrate drug similarity information; (3) all drugs were ranked ...
Dan‐Yang Liu +21 more
wiley +1 more source
Conclusion: Despite evidence of efficacy in refractory vasodilatory shock secondary to sepsis, there is a paucity of data on the use of angiotensin II as an adjunctive vasopressor in drug-induced shock.
John H. Keller +2 more
doaj +1 more source
Beyond blood pressure: new roles for angiotensin II
Ralph Lucius +4 more
openalex +2 more sources
Antiangiogenic therapy with bevacizumab improves outcomes in ovarian cancer but induces hypertension, leading to major adverse cardiovascular events (MACE). While calcium channel blockers (CCBs) and angiotensin‐converting enzyme inhibitors (ACEi) are recommended for managing bevacizumab‐associated hypertension, their impacts on cancer progression and ...
Floriane Jochum +10 more
wiley +1 more source
Hypertension, Small Arteries, and Pathways for Angiotensin II Generation [PDF]
Norman K. Hollenberg
openalex +1 more source

